INVESTORS + MEDIA

Aerami Therapeutics is developing a new generation of inhaled therapies for the treatment of severe respiratory diseases. Our platform is designed to overcome the limitations of injectable, oral, and other inhaled formulation technologies for managing severe respiratory diseases. Ultimately, our aim is to improve treatment efficacy and improve patient lives.